Jeffrey S. Hackman - Net Worth and Insider Trading
Jeffrey S. Hackman Net Worth
The estimated net worth of Jeffrey S. Hackman is at least $130,960 dollars as of 2025-07-24. Jeffrey S. Hackman is the CEO of Fennec Pharmaceuticals Inc and owns about 15,000 shares of Fennec Pharmaceuticals Inc (FENC) stock worth over $130,950. Jeffrey S. Hackman is also the See Remarks of Comera Life Sciences Holdings Inc and owns about 47,600 shares of Comera Life Sciences Holdings Inc (CMRA) stock worth over $10. Details can be seen in Jeffrey S. Hackman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeffrey S. Hackman has not made any transactions after 2025-05-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Jeffrey S. Hackman
Jeffrey S. Hackman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeffrey S. Hackman owns 1 companies in total, including Comera Life Sciences Holdings Inc (CMRA) .
Click here to see the complete history of Jeffrey S. Hackman’s form 4 insider trades.
Insider Ownership Summary of Jeffrey S. Hackman
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
CMRA | Comera Life Sciences Holdings Inc | 2022-09-09 | director & See Remarks |
Jeffrey S. Hackman Latest Holdings Summary
Jeffrey S. Hackman currently owns a total of 2 stocks. Among these stocks, Jeffrey S. Hackman owns 15,000 shares of Fennec Pharmaceuticals Inc (FENC) as of May 19, 2025, with a value of $130,950 and a weighting of 99.99%. Jeffrey S. Hackman also owns 47,600 shares of Comera Life Sciences Holdings Inc (CMRA) as of September 9, 2022, with a value of $10 and a weighting of 0.01%.
Latest Holdings of Jeffrey S. Hackman
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
FENC | Fennec Pharmaceuticals Inc | 2025-05-19 | 15,000 | 8.73 | 130,950 |
CMRA | Comera Life Sciences Holdings Inc | 2022-09-09 | 47,600 | 0.00 | 10 |
Holding Weightings of Jeffrey S. Hackman
Jeffrey S. Hackman Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeffrey S. Hackman has made a total of 1 transactions in Fennec Pharmaceuticals Inc (FENC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Fennec Pharmaceuticals Inc is the acquisition of 15,000 shares on May 19, 2025, which cost Jeffrey S. Hackman around $104,550.
According to the SEC Form 4 filings, Jeffrey S. Hackman has made a total of 1 transactions in Comera Life Sciences Holdings Inc (CMRA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Comera Life Sciences Holdings Inc is the acquisition of 47,600 shares on September 9, 2022, which cost Jeffrey S. Hackman around $98,056.
Insider Trading History of Jeffrey S. Hackman
- 1
Jeffrey S. Hackman Trading Performance
GuruFocus tracks the stock performance after each of Jeffrey S. Hackman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeffrey S. Hackman is -30.2%. GuruFocus also compares Jeffrey S. Hackman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeffrey S. Hackman within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jeffrey S. Hackman's insider trading performs compared to the benchmark.
Performance of Jeffrey S. Hackman
Jeffrey S. Hackman Ownership Network
Ownership Network List of Jeffrey S. Hackman
Ownership Network Relation of Jeffrey S. Hackman

Jeffrey S. Hackman Owned Company Details
What does Comera Life Sciences Holdings Inc do?
Who are the key executives at Comera Life Sciences Holdings Inc?
Jeffrey S. Hackman is the director & See Remarks of Comera Life Sciences Holdings Inc. Other key executives at Comera Life Sciences Holdings Inc include Chief Financial Officer Michael Gerard Campbell , 10 percent owner Charles Cherington , and 10 percent owner David Soane .
Comera Life Sciences Holdings Inc (CMRA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Comera Life Sciences Holdings Inc (CMRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Comera Life Sciences Holdings Inc (CMRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Comera Life Sciences Holdings Inc (CMRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Comera Life Sciences Holdings Inc Insider Transactions
Jeffrey S. Hackman Mailing Address
Above is the net worth, insider trading, and ownership report for Jeffrey S. Hackman. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Jeffrey S. Hackman's mailing address is: Woburn Ma 01801.